dual Factor IIa/Factor Xa inhibitor (Bayer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual Factor IIa/Factor Xa inhibitor (Bayer)
Drug Alias Namedual Factor Xa/Factor IIa inhibitor (Bayer)dual thrombin/Factor Xa inhibitor (Bayer)BAY-878
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitorsCoagulation factor X inhibitors
TargetsCoagulation factor XProthrombin
Therapy Area/IndicationsThrombosisMyocardial InfarctionCoronary Artery Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial InfarctionCoronary Artery Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A